“The move comes after Shkreli, its former CEO, was charged on December 17 in federal court with securities fraud related to a hedge fund and another company. Shkreli pleaded not guilty to the charges.  Shkreli initially gained notoriety in September when, as the chief executive of Turing Pharmaceuticals, he raised the price of Daraprim— a drug used to treat a dangerous parasitic infection— from $13.50 to $750 per pill.  The move generated harsh criticism from prominent politicians, including Hillary Clinton, and spurred a senate investigation into drug pricing.”

http://www.nydailynews.com/news/national/martin-shkreli-company-files-bankruptcy-article-1.2481147

Did you like this?
Tip Freedomwat.ch Staff with Bitcoin

Donate via Installed Wallet Copy